General Information
Revision date
2021-04-17
Product name
Tolvaptan Tablets
Manufacturer Name
Annora Pharma Private Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H312, H332
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
CLP CLASSIFICATION
Classification according to Regulation (EC) No. 1272/2008 [CLP] ]] Not classified
EU Classification
Directive Carc.Cat.3; R40 (Limited evidence of a carcinogenic effect) 67/548/EEC or 1999/45/EC
Adverse physicochemical, human health and environmental effects
No additional information available Labelling according to Regulation (EC) No. 1272/2008 [CLP]
Hazard statements
H302 - Harmful if swallowed H312 - Harmful in contact with skin H332 - Harmful if inhaled
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand P102 - Keep out of reach of children P103 - Read label before use P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood
Supplemental label elements
EUH210 - Safety data sheet available on request
